Relationship between GFR, intact PTH, oxidized PTH, non‐oxidized PTH as well as FGF23 in patients with CKD-Reference-Cited by-同舟云学术

Relationship between GFR, intact PTH, oxidized PTH, non‐oxidized PTH as well as FGF23 in patients with CKD

Published:2020-09-22 Issue:11 Volume:34 Page:15269-15281
ISSN:0892-6638
Container-title:The FASEB Journal
language:en
Short-container-title:FASEB j.

Author:

Zeng Shufei¹²,Querfeld Uwe³,Feger Martina⁴,Haffner Dieter⁵,Hasan Ahmed A.¹⁶,Chu Chang¹²,Slowinski Torsten²,Bernd Dschietzig Thomas⁷,Schäfer Franz⁸,Xiong Yingquan¹⁶,Zhang Bingbing⁹¹⁰,Rausch Steffen⁴,Horvathova Katarina¹¹,Lang Florian⁶,Karl Krämer Bernhard¹,Föller Michael⁴,Hocher Berthold¹¹²¹³¹⁴

Affiliation:

1. Fifth Department of Medicine (Nephrology/Endocrinology/Rheumatology) University Medical Centre MannheimUniversity of Heidelberg Heidelberg Germany

2. Department of Nephrology Charité‐Universitätsmedizin Berlin Berlin Germany

3. Division of Gastroenterology, Nephrology and Metabolic Diseases Department of Pediatrics Charité‐Universitätsmedizin Berlin Berlin Germany

4. Department of Physiology University of Hohenheim Stuttgart Germany

5. Department of Pediatric Kidney, Liver and Metabolic Diseases Pediatric Research Center Hannover Medical School Hannover Germany

6. Institute of Nutritional Science University of Potsdam Potsdam Germany

7. Department of Cardiology Charité‐Universitätsmedizin Berlin Berlin Germany

8. Center for Pediatrics and Adolescent Medicine University of Heidelberg Heidelberg Germany

9. Institute of Physiology University of Tübingen Tübingen Germany

10. College of Life Science and Technology Heilongjiang Bayi Agricultural University Daqing China

11. Biomedica Slovakia s.r.o. Bratislava Slovakia

12. Key Laboratory of Study and Discovery of Small Targeted Molecules of Hunan Province School of Medicine Hunan Normal University Changsha China

13. Reproductive and Genetic Hospital of CITIC‐Xiangya Changsha China

14. Institute of Medical Diagnostics IMD, Berlin , Berlin Germany

Funder

China Scholarship Council

Publisher

Wiley

Subject

Genetics,Molecular Biology,Biochemistry,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1096/fj.202000596R

Reference48 articles.

1. FGF23-αKlotho as a paradigm for a kidney-bone network

2. Fibroblast growth factor-23 regulates parathyroid hormone and 1α-hydroxylase expression in cultured bovine parathyroid cells

3. Longitudinal FGF23 Trajectories and Mortality in Patients with CKD

4. Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease

5. The complexity of chronic kidney disease–mineral and bone disorder across stages of chronic kidney disease

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non-Classical Effects of FGF23: Molecular and Clinical Features;International Journal of Molecular Sciences;2024-04-30

2. Only bioactive forms of PTH (n-oxPTH and Met18(ox)-PTH) inhibit synthesis of sclerostin – evidence from in vitro and human studies;Pflügers Archiv - European Journal of Physiology;2024-02-23

3. Inverse correlation of intact PTH, oxidized PTH as well as non-oxidized PTH with 25-hydroxyvitamin D3 in kidney transplant recipients;Frontiers in Endocrinology;2023-05-31

4. Association between CKD-MBD and mortality in older patients with advanced CKD—results from the EQUAL study;Nephrology Dialysis Transplantation;2023-05-25

5. Oncostatin M is a regulator of fibroblast growth factor 23 (FGF23) in UMR106 osteoblast-like cells;Scientific Reports;2023-05-24